Dr. Melissa Medvedev (Morgan) is a physician-scientist with a background in clinical research, global health, and health technology innovation. Her research focuses on evaluating interventions to promote survival and prevent disability in mothers, neonates, and children. She co-led the OMWaNA trial, which compared the effectiveness, safety, costs, and cost-effectiveness of kangaroo mother care initiated before stabilization vs. standard care among neonates weighing 2000g or less at five hospitals in Uganda. She is a co-investigator on the VIVANT study, a RCT evaluating whether oral azithromycin improves growth and infectious morbidity in low birthweight and underweight neonates across 45 health facilities in Burkina Faso.
Dr. Medvedev is the Founding Editor-in-Chief of Nature/npj Women's Health. She is a member of the WHO/ UNICEF Every Newborn Measurement Improvement KMC Working Group, the UNICEF/NEST360 Target Product Profiles Working Group, the NEST360 Education and COVID-19 Working Groups, and the COVID-19 Small and Sick Newborn Care Collaborative Group (in partnership with WHO, UNICEF, and NEST360). She previously served as an Associate Editor of Nature/npj Digital Medicine.